Metformin inhibits non-small cell lung cancer via lncRP11-242D8.1

Key Points

• Metformin significantly reduces the proliferation of non-small cell lung cancer cells, enhancing apoptosis.
• The study reports a 40% decrease in tumor size among treated subjects within 12 weeks of intervention.
• Assessment using intracellular signaling pathways related to lncRP11-242D8.1 showed altered expression profiles.
• This finding supports the potential use of metformin as a therapeutic agent for lung cancer treatment.